Cleared Traditional

K052790 - SMARTSITE VENTED VIAL ACCESS DEVICE, MODEL TBD

K052790 is an FDA 510(k) clearance for SMARTSITE VENTED VIAL ACCESS DEVICE, manufactured by Cardinal Health, Alaris Products. The device is a Class 2 General Hospital device with product code LHI cleared through the Traditional 510(k) pathway after a 81-day FDA review.

K052790 · Cardinal Health, Alaris Products · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2005
Decision
81d
Days
Class 2
Risk

K052790 is an FDA 510(k) clearance for the SMARTSITE VENTED VIAL ACCESS DEVICE, MODEL TBD. Classified as Set, I.v. Fluid Transfer (product code LHI), Class II - Special Controls.

Submitted by Cardinal Health, Alaris Products (San Diego, US). The FDA issued a Cleared decision on December 23, 2005 after a review of 81 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Cardinal Health, Alaris Products devices

FDA 510(k) Submission Details - K052790

510(k) Number K052790 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 03, 2005
Decision Date December 23, 2005
Days to Decision 81 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
48d faster than avg
Panel avg: 129d · This submission: 81d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LHI Device Classification - Class 2, Special Controls

Product Code LHI Set, I.v. Fluid Transfer
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - LHI Set, I.v. Fluid Transfer

All 160
Devices cleared under the same product code (LHI) and FDA review panel - the closest regulatory comparables to K052790.
TEVADAPTOR, CLOSED DRUG RECONSTITUTION AND TRANSFER SYSTEM
K071741 · Migada Plant · Sep 2007
VENTED VIAL ADAPTER TRANSFER DEVICE
K062482 · Medimop Medical Projects, Ltd. · Nov 2006
PHASEAL - CLOSED SYSTEM FOR THE PREPARATION AND ADMINISTRATION OF PARENTERAL DRUGS
K060866 · Carmel Pharma Ab. · Apr 2006
TEVADAPTOR CLOSED DRUG RECONSTITUTION AND TRANSFER SYSTEM
K051669 · Migada Plant · Sep 2005
SET GRI-FILL 3.0-1 WAY, 2 WAYS, MULTIPLE
K050339 · Laboratorios Grifols, S.A. · Feb 2005
Q-CAP NEEDLE-FREE RECONSTITUTION 13MM VIAL ADAPTER, MODEL 6100-01
K043304 · Bioject Medical Technologies, Inc. · Jan 2005